Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Administration, Inhalation"" wg kryterium: Temat


Tytuł:
A whole lung in silico model to estimate age dependent particle dosimetry.
Autorzy:
Poorbahrami K; Department of Mechanical and Industrial Engineering, Northeastern University, Boston, USA.
Vignon-Clementel IE; Inria Saclay-Ile-de-France, Inria, France.
Shadden SC; Department of Mechanical Engineering, University of California Berkeley, Berkeley, USA.
Oakes JM; Department of Bioengineering, Northeastern University, Boston, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 May 27; Vol. 11 (1), pp. 11180. Date of Electronic Publication: 2021 May 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Administration, Inhalation*
Aerosols*
Lung*
Models, Theoretical*
Adult ; Child ; Computer Simulation ; Humans ; Infant
Czasopismo naukowe
Tytuł:
Low-temperature (< 200 °C) degradation of electronic nicotine delivery system liquids generates toxic aldehydes.
Autorzy:
Jaegers NR; Pacific Northwest National Laboratory, Richland, WA, 99354, USA.
Hu W; Pacific Northwest National Laboratory, Richland, WA, 99354, USA.
Weber TJ; Pacific Northwest National Laboratory, Richland, WA, 99354, USA.
Hu JZ; Pacific Northwest National Laboratory, Richland, WA, 99354, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Apr 08; Vol. 11 (1), pp. 7800. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Administration, Inhalation*
Electronic Nicotine Delivery Systems*
Temperature*
Aldehydes/*chemistry
Vaping/*adverse effects
Humans
Czasopismo naukowe
Tytuł:
Inhalation dosimetry of nasally inhaled respiratory aerosols in the human respiratory tract with locally remodeled conducting lungs.
Autorzy:
Si XA; Department of Mechanical Engineering, California Baptist University, Riverside, CA, USA.
Talaat M; Department of Biomedical Engineering, University of Massachusetts, Lowell, MA, USA.
Su WC; Department of Epidemiology, Human Genetics, and Environmental Science, University of Texas Health Science Center at Houston, Houston, TX, USA.
Xi J; Department of Biomedical Engineering, University of Massachusetts, Lowell, MA, USA.
Pokaż więcej
Źródło:
Inhalation toxicology [Inhal Toxicol] 2021 Mar; Vol. 33 (4), pp. 143-159. Date of Electronic Publication: 2021 Apr 18.
Typ publikacji:
Journal Article
MeSH Terms:
Administration, Inhalation*
Airway Remodeling*
Aerosols/*administration & dosage
Nanoparticles/*administration & dosage
Dose-Response Relationship, Drug ; Humans ; Lung/anatomy & histology ; Lung/pathology ; Models, Biological ; Nose/anatomy & histology
Czasopismo naukowe
Tytuł:
Perceptions, attitudes, and behaviors of asthma patients towards the use of short-acting β2-agonists: A systematic review.
Autorzy:
Loh ZC; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor, Pulau Pinang, Malaysia.
Hussain R; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor, Pulau Pinang, Malaysia.
Balan S; Pharmacy Department, Hospital Tengku Ampuan Rahimah, Klang, Selangor, Malaysia.
Saini B; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Muneswarao J; Pharmacy Department, Hospital Pulau Pinang, George Town, Pulau Pinang, Malaysia.
Ong SC; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor, Pulau Pinang, Malaysia.
Babar ZU; Department of Pharmacy, University of Huddersfield, Huddersfield, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Apr 20; Vol. 18 (4), pp. e0283876. Date of Electronic Publication: 2023 Apr 20 (Print Publication: 2023).
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Asthma*/drug therapy
Asthma*/diagnosis
Anti-Asthmatic Agents*/therapeutic use
Humans ; Health Personnel ; Databases, Factual ; Administration, Inhalation
Czasopismo naukowe
Tytuł:
Comparative Aspects of Ricin Toxicity by Inhalation.
Autorzy:
Stoll A; Defence Science and Technology Laboratory, Salisbury SP4 0JQ, UK.
Shenton DP; Defence Science and Technology Laboratory, Salisbury SP4 0JQ, UK.
Green AC; Defence Science and Technology Laboratory, Salisbury SP4 0JQ, UK.
Holley JL; Defence Science and Technology Laboratory, Salisbury SP4 0JQ, UK.
Pokaż więcej
Źródło:
Toxins [Toxins (Basel)] 2023 Apr 13; Vol. 15 (4). Date of Electronic Publication: 2023 Apr 13.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Ricin*/toxicity
Animals ; Rabbits ; Swine ; Lung/pathology ; Macaca mulatta ; Administration, Inhalation ; Fibrosis
Czasopismo naukowe
Tytuł:
Outcome of obstructed total anamalous pulmonary venous connection (TAPVC) repair patients with milrinone versus milrinone and inhaled nitric oxide (INO): A prospective randomized observational study.
Autorzy:
Gujja S; Department of Cardiac Anesthesia, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India.
Prajapati M; Department of Cardiac Anesthesia, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India.
Chuada TR; Department of Cardiac Anesthesia, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India.
Gandhi H; Department of Cardiac Anesthesia, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India.
Arora V; Department of Cardiac Anesthesia, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India.
Kaul V; Department of Cardiac Anesthesia, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India.
Patel S; Research, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India.
Pokaż więcej
Źródło:
Annals of cardiac anaesthesia [Ann Card Anaesth] 2023 Apr-Jun; Vol. 26 (2), pp. 177-182.
Typ publikacji:
Randomized Controlled Trial; Observational Study; Journal Article
MeSH Terms:
Lung Diseases*
Hypertension, Pulmonary*/drug therapy
Humans ; Milrinone/therapeutic use ; Nitric Oxide/therapeutic use ; Prospective Studies ; Administration, Inhalation
Czasopismo naukowe
Tytuł:
Comparing inhaled colistin with inhaled fosfomycin/tobramycin as an adjunctive treatment for ventilator-associated pneumonia: An open-label randomized controlled trial.
Autorzy:
Hakamifard A; Department of Infectious Diseases, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Torfeh Esfahani AA; Department of Infectious Diseases, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Homayouni A; Research and Development Department, Goldaru Pharmaceutical Company, Isfahan, Iran.; Department of Pharmaceutics, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.
Khorvash F; Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Ataei B; Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Abbasi S; Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.; Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2023 Apr; Vol. 17 (4), pp. 295-302. Date of Electronic Publication: 2023 Feb 12.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Fosfomycin*/therapeutic use
Pneumonia, Ventilator-Associated*/drug therapy
Pneumonia, Bacterial*
Humans ; Colistin/therapeutic use ; Tobramycin ; Treatment Outcome ; Anti-Bacterial Agents/therapeutic use ; Administration, Inhalation
Czasopismo naukowe
Tytuł:
Increased inhaled corticosteroids for treating acute asthma exacerbations.
Autorzy:
Ramphul M; Department of Paediatric Respiratory Medicine, Leicester Royal Infirmary, Leicester, United Kingdom.
Pokaż więcej
Źródło:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2023 Apr; Vol. 53 (4), pp. 388-391. Date of Electronic Publication: 2023 Mar 28.
Typ publikacji:
Editorial
MeSH Terms:
Adrenal Cortex Hormones*/administration & dosage
Adrenal Cortex Hormones*/therapeutic use
Anti-Asthmatic Agents*/administration & dosage
Anti-Asthmatic Agents*/therapeutic use
Asthma*/drug therapy
Humans ; Administration, Inhalation
Opinia redakcyjna
Tytuł:
The impact of impaired sleep quality on symptom change and future exacerbation of chronic obstructive pulmonary disease.
Autorzy:
Lin L; Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, Hunan, 410011, China.; Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.; Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.
Song Q; Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, Hunan, 410011, China.; Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.; Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.
Duan J; Geriatrics Department, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Liu C; Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, Hunan, 410011, China.; Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.; Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.
Cheng W; Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, Hunan, 410011, China.; Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.; Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.
Zhou A; Center of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Peng Y; Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, Hunan, 410011, China.; Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.; Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.
Zhou Z; Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, Hunan, 410011, China.; Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.; Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.
Zeng Y; Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, Hunan, 410011, China.; Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.; Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.
Chen Y; Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, Hunan, 410011, China.; Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.; Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.
Cai S; Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, Hunan, 410011, China.; Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.; Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China.
Chen P; Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, Hunan, 410011, China. .; Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China. .; Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, China. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2023 Mar 30; Vol. 24 (1), pp. 98. Date of Electronic Publication: 2023 Mar 30.
Typ publikacji:
Journal Article
MeSH Terms:
Sleep Quality*
Pulmonary Disease, Chronic Obstructive*/diagnosis
Pulmonary Disease, Chronic Obstructive*/epidemiology
Pulmonary Disease, Chronic Obstructive*/drug therapy
Humans ; Prospective Studies ; Disease Progression ; Risk Factors ; Adrenergic beta-2 Receptor Agonists ; Muscarinic Antagonists ; Administration, Inhalation ; Adrenal Cortex Hormones
Czasopismo naukowe
Tytuł:
Large eddy simulation of droplet transport and deposition in the human respiratory tract to evaluate inhalation risk.
Autorzy:
Murga A; Kobe University, Graduate School of System Informatics, Japan.
Bale R; Kobe University, Graduate School of System Informatics, Japan.; Riken Center for Computational Sciences, Japan.
Li CG; National Cheng Kung University, Taiwan.
Ito K; Kyushu University, Faculty of Engineering Sciences, Japan.
Tsubokura M; Kobe University, Graduate School of System Informatics, Japan.; Riken Center for Computational Sciences, Japan.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2023 Mar 20; Vol. 19 (3), pp. e1010972. Date of Electronic Publication: 2023 Mar 20 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
SARS-CoV-2*
COVID-19*
Humans ; Respiratory System ; Administration, Inhalation ; Respiration
Czasopismo naukowe
Tytuł:
Inhaled Nitric Oxide Promotes Angiogenesis in the Rodent Developing Brain.
Autorzy:
Loron G; Service de Médecine Néonatale et de Réanimation Pédiatrique, Université de Reims Champagne-Ardenne, CReSTIC, CHU Reims, 51100 Reims, France.
Pansiot J; Inserm, NeuroDiderot, Faculty of Medicine, Université Paris Cité, 75019 Paris, France.
Olivier P; Inserm, NeuroDiderot, Faculty of Medicine, Université Paris Cité, 75019 Paris, France.
Charriaut-Marlangue C; Inserm, NeuroDiderot, Faculty of Medicine, Université Paris Cité, 75019 Paris, France.
Baud O; Inserm, NeuroDiderot, Faculty of Medicine, Université Paris Cité, 75019 Paris, France.; Division of Neonatology and Pediatric Intensive Care, Children's University Hospital of Geneva, 1205 Geneva, Switzerland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 20; Vol. 24 (6). Date of Electronic Publication: 2023 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Nitric Oxide*/metabolism
Rodentia*/metabolism
Animals ; Rats ; Animals, Newborn ; Soluble Guanylyl Cyclase/metabolism ; Vascular Endothelial Growth Factor A/metabolism ; Brain/metabolism ; Administration, Inhalation
Czasopismo naukowe
Tytuł:
Impact of dispersion media and carrier type on spray-dried proliposome powder formulations loaded with beclomethasone dipropionate for their pulmonary drug delivery via a next generation impactor.
Autorzy:
Khan I; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom.
Al-Hasani A; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom.
Khan MH; Surgical A Ward, Khyber Teaching Hospital, Peshawar, Pakistan.
Khan AN; Cardiology Department, Lady Reading Hospital, Peshawar, Pakistan.
-Alam FE; Department of Hepatology, King's College Hospital, Denmark Hill, London, United Kingdom.
Sadozai SK; Department of Pharmacy, Kohat University of Science and Technology, Kohat, Pakistan.
Elhissi A; Pharmaceutical Sciences Section, College of Pharmacy, Qatar University, Doha, Qatar.
Khan J; Zia Medical Centre, Abu Dhabi, UAE.
Yousaf S; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Mar 13; Vol. 18 (3), pp. e0281860. Date of Electronic Publication: 2023 Mar 13 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Beclomethasone*
Lactose*
Powders ; Particle Size ; Administration, Inhalation ; Dry Powder Inhalers ; Ethanol ; Water ; Lipids ; Aerosols ; Drug Carriers
Czasopismo naukowe
Tytuł:
Surface Modification of lactose carrier particles using a fluid bed coater to improve fine particle fraction for dry powder inhalers.
Autorzy:
Gong QQ; GEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, Singapore, Singapore.; Engineering Technology Research Center for Processing and Preparation of Traditional Chinese Medicine and Ethnic Medicine, National Engineering Technology Research Center for Miao Medicine, College of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Tay JYS; GEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, Singapore, Singapore.
Veronica N; GEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, Singapore, Singapore.
Xu J; Engineering Technology Research Center for Processing and Preparation of Traditional Chinese Medicine and Ethnic Medicine, National Engineering Technology Research Center for Miao Medicine, College of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Heng PWS; GEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, Singapore, Singapore.
Zhang YP; Engineering Technology Research Center for Processing and Preparation of Traditional Chinese Medicine and Ethnic Medicine, National Engineering Technology Research Center for Miao Medicine, College of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Liew CV; School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Selangor, Malaysia.
Pokaż więcej
Źródło:
Pharmaceutical development and technology [Pharm Dev Technol] 2023 Feb; Vol. 28 (2), pp. 164-175. Date of Electronic Publication: 2023 Jan 26.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Carriers*
Dry Powder Inhalers*/methods
Lactose*
Administration, Inhalation ; Aerosols ; Albuterol ; Drug Delivery Systems/methods ; Excipients ; Particle Size ; Powders ; Surface Properties
Czasopismo naukowe
Tytuł:
Sodium hyaluronate dry powder inhalation in combination with sodium cromoglycate prepared using optimized spray drying conditions.
Autorzy:
Yildiz Türkyilmaz G; Center For Drug R&D and Pharmacokinetic Applications (ARGEFAR), Ege University, İzmir, Türkiye.; Department of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, Ege University, Izmir, Türkiye.
Özdokur KV; Department of Chemistry, Faculty of Science and Letter, Erzincan Binali Yıldırım University, Erzincan, Türkiye.
Alparslan L; Department of Pharmaceutical Technology, Faculty of Pharmacy, Istinye University, Istanbul, Türkiye.
Karasulu E; Center For Drug R&D and Pharmacokinetic Applications (ARGEFAR), Ege University, İzmir, Türkiye.; Department of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, Ege University, Izmir, Türkiye.
Pokaż więcej
Źródło:
Pharmaceutical development and technology [Pharm Dev Technol] 2023 Feb; Vol. 28 (2), pp. 240-247. Date of Electronic Publication: 2023 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
Cromolyn Sodium*
Hyaluronic Acid*
Powders/chemistry ; Spray Drying ; Lactose/chemistry ; Administration, Inhalation ; Aerosols/chemistry ; Particle Size ; Dry Powder Inhalers
Czasopismo naukowe
Tytuł:
Landscape of short-acting beta-agonists (SABA) overuse in Europe.
Autorzy:
de Las Vecillas L; Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain.
Quirce S; Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain.
Pokaż więcej
Źródło:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2023 Feb; Vol. 53 (2), pp. 132-144. Date of Electronic Publication: 2022 Dec 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Asthma*/drug therapy
Asthma*/epidemiology
Asthma*/chemically induced
Anti-Asthmatic Agents*/adverse effects
Humans ; Europe/epidemiology ; Administration, Inhalation
Czasopismo naukowe
Tytuł:
Cough as an adverse effect on inhalation pharmaceutical products.
Autorzy:
Chang RYK; Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
Kwok PCL; Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
Ghassabian S; Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
Brannan JD; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia.
Koskela HO; Unit for Medicine and Clinical Research, Pulmonary Division, Kuopio University Hospital, Kuopio, Finland.; School of Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
Chan HK; Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2020 Sep; Vol. 177 (18), pp. 4096-4112. Date of Electronic Publication: 2020 Aug 07.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Administration, Inhalation*
Bronchoconstriction*
Cough*/chemically induced
Aerosols/therapeutic use ; Humans ; Lung ; Particle Size
Czasopismo naukowe
Tytuł:
Numerical evaluation of spray position for improved nasal drug delivery.
Autorzy:
Basu S; Department of Mechanical Engineering, South Dakota State University, Brookings, SD, 57007, United States. .
Holbrook LT; Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC, 27599, United States.
Kudlaty K; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Fasanmade O; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Wu J; Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC, 27599, United States.
Burke A; Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC, 27599, United States.
Langworthy BW; Department of Biostatistics, University of North Carolina, Chapel Hill, NC, 27599, United States.
Farzal Z; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Mamdani M; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Bennett WD; Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC, 27599, United States.
Fine JP; Department of Biostatistics, University of North Carolina, Chapel Hill, NC, 27599, United States.
Senior BA; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Zanation AM; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Ebert CS Jr; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Kimple AJ; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Thorp BD; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Frank-Ito DO; Department of Head and Neck Surgery & Communication Sciences, Duke University Medical Center, Durham, NC, 27708, United States.
Garcia GJM; Joint Department of Biomedical Engineering, Medical College of Wisconsin and Marquette University, Milwaukee, WI, 53226, United States.
Kimbell JS; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Jun 29; Vol. 10 (1), pp. 10568. Date of Electronic Publication: 2020 Jun 29.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Administration, Inhalation*
Betacoronavirus*
Nasal Sprays*
Administration, Intranasal/*methods
Coronavirus Infections/*prevention & control
Drug Delivery Systems/*methods
Pandemics/*prevention & control
Pneumonia, Viral/*prevention & control
COVID-19 ; Computer Simulation ; Coronavirus Infections/virology ; Humans ; Hydrodynamics ; Nasal Cavity/anatomy & histology ; Nasal Mucosa/drug effects ; Nasal Mucosa/virology ; Nebulizers and Vaporizers ; Paranasal Sinuses/drug effects ; Paranasal Sinuses/virology ; Pneumonia, Viral/virology ; SARS-CoV-2 ; Viral Vaccines/administration & dosage
Czasopismo naukowe
Tytuł:
In 'real world' patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations.
Autorzy:
Worth H; Facharztforum Fürth, 90762, Fürth, Germany. .
Buhl R; Pulmonary Department, Mainz University Hospital, 55131, Mainz, Germany.
Criée CP; Department of Sleep and Respiratory Medicine, Evangelical Hospital Goettingen-Weende, 37120, Bovenden, Germany.
Kardos P; Group Practice and Centre for Allergy, Respiratory and Sleep Medicine, Red Cross Maingau Hospital, 60316, Frankfurt am Main, Germany.
Gückel E; Clinical Research, Respiratory, Novartis Pharma GmbH, 90429, Nürnberg, Germany.
Vogelmeier CF; Department of Medicine, Pulmonary and Critical Care Medicine, German Center for Lung Research (DZL), University Medical Centre Giessen and Marburg, Philipps-University Marburg, 35043, Marburg, Germany.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2023 Jan 05; Vol. 24 (1), pp. 2. Date of Electronic Publication: 2023 Jan 05.
Typ publikacji:
Letter
MeSH Terms:
Eosinophils*
Pulmonary Disease, Chronic Obstructive*/diagnosis
Pulmonary Disease, Chronic Obstructive*/drug therapy
Pulmonary Disease, Chronic Obstructive*/chemically induced
Humans ; Drug Therapy, Combination ; Adrenergic beta-2 Receptor Agonists ; Administration, Inhalation ; Disease Progression ; Muscarinic Antagonists ; Adrenal Cortex Hormones/therapeutic use ; Bronchodilator Agents
Opinia redakcyjna
Tytuł:
Editorial comment on: Short-acting β 2-agonist use and asthma exacerbations in Swedish children: A SABINA Junior study.
Autorzy:
Boccabella C; Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario 'A Gemelli' - IRCCS, University of the Sacred Heart, Rome, Italy.
Kalayci O; Pediatric Allergy and Asthma Unit, Hacettepe University School of Medicine, Ankara, Turkey.
Eigenmann P; Pediatric Allergy Unit, Department of Women-Children-Teenagers, University Hospitals of Geneva, Geneva, Switzerland.
Pokaż więcej
Źródło:
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2023 Jan; Vol. 34 (1), pp. e13910.
Typ publikacji:
Editorial
MeSH Terms:
Asthma*/drug therapy
Asthma*/epidemiology
Anti-Asthmatic Agents*/therapeutic use
Child ; Humans ; Sweden/epidemiology ; Bronchodilator Agents/therapeutic use ; Administration, Inhalation ; Adrenal Cortex Hormones/therapeutic use
Opinia redakcyjna
Tytuł:
Nanoparticle-containing lyophilized dry powder inhaler formulations optimized using central composite design with improved aerodynamic parameters and redispersibility.
Autorzy:
Akdag Y; Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
Pokaż więcej
Źródło:
Pharmaceutical development and technology [Pharm Dev Technol] 2023 Jan; Vol. 28 (1), pp. 124-137. Date of Electronic Publication: 2023 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Dry Powder Inhalers*
Nanoparticles*/chemistry
Humans ; Administration, Inhalation ; A549 Cells ; Particle Size ; Aerosols ; Powders
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies